In an effort to sway policymakers to address opioid abuse, identity solutions provider HID Global presented its ideas and expertise in electronic prescriptions at the opioid policy hearing hosted by the Food & Drug Administration.
HID urges FDA to consider the link between electronic prescriptions for controlled substances with prescription drug monitoring databases. With electronic prescriptions, HID Global believes it will serve as an additional precaution to doctors who prescribe painkillers to their patients.
Automated tracking, improved risk assessments, increased efficiencies and better communication also fall under the benefits available through e-prescriptions. Transactions are digitally signed by prescribers with secure and non-reputable digital certificates supplied by HID’s IdenTrrust platform, a secure, heavily-encrypted two-factor authentication digital certificate platform.
“We believe that electronic prescriptions would curb the over-prescribing of opioids and prevent the highly addictive drugs from falling into the wrong hands. People’s lives will be saved,” HID Global’s Vice President of IAM Solutions Brad Jarvis said.